Nilotinib Tasigna – New Treatment for Alzheimer's Alzheimer's disease is a brain disorder that destroys the nerve connections in the brain and further slowly destroys memory and thinking skills; makes difficult to do regular things like eating, and walking. • In short Alzheimer's can cause memory loss and can affect the cognitive abilities, this disease is not as normal as someone thinks and it mostly affects the people who are above 65 years. • Alzheimer's become worse with time. Dementia symptoms become worse gradually over the years. In the early stages, memory loss is mild, but with late-stage Alzheimer's, individuals face problem in having a conversation with others and face difficulties to cope with the environment. Alzheimer's in the USA is the 6th leading cause of death of an individual. • A person suffering from this disease has around 4-8 years of life expectancy after he has been diagnosed. Source: https://www.genuinedrugs123.com/Blog-154-NILOTINIB-TASIGNA%E2%80%93NEW-TREATMENT-FOR-ALZHEIMERS.aspx #Nilotinib #Tasigna #Alzheimers #NewTreatment #HopeForAlzheimers #AlzheimersResearch #BrainHealth #Neurology #Medication #Healthcare #AlzheimersAwareness #MedicalAdvancements #ClinicalTrials #Neuroscience #AlzheimersSupport #TreatmentOptions

Nilotinib as an alternate medication for Imatinib-Resistant CML https://www.genuinedrugs123.com/Blog-134-Nilotinib-as-an-alternate-medication-for-Imatinib-Resistant-CML.aspx - Chronic Myeloid Leukemia or CML forms from the clonal expansion of stem cells (pluripotent hematopoietic) that contains an active fusion gene / protein known as BCR/ABL. This protein shows organized tyrosine activity and enables the leukemic cells to grow and also provide resistance to apoptosis.